Speaker(s): Margaret Jarvis, MD, Geisinger

Moderator: Dominick Agosti, LCSW, Geisinger

 

Learning Objectives

At the conclusion of this session, the participant should be able to:

  • Differentiate buprenorphine from other opiates.
  • Detail how buprenorphine is used to treat OUD.
  • Explain Geisinger’s buprenorphine model.
Session date: 
10/12/2023 - 8:00am to 9:00am EDT
Location: 
Virtual
United States
  • 0.00 AAPA Category I CME
  • 1.00 ACPE
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 ANCC
  • 1.00 Participation Credit
Please login or register to take this course.